- Clear All
- Remove theJAVMA Newsfilter JAVMA News
- Remove thePolicyfilter Policy
- Remove theInternal medicinefilter Internal medicine
- Remove theToxicologyfilter Toxicology
- Remove theAnimal healthfilter Animal health
- Remove theDrugs & vaccinesfilter Drugs & vaccines
- Remove thePractice operationsfilter Practice operations
- Remove theProduction medicinefilter Production medicine
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
Iowa State confers Stange, Switzer awards
Four alumni of the Iowa State University College of Veterinary Medicine were honored Oct. 29, 2016.
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
Veterinarians could lead sustainability efforts
Despite the veterinary community championing the one-health concept—that human, animal, and environmental health are intertwined—the environmental…